Curriculum Vitae


1988 - 1994          Licenciado en Medicina. UNC, Mendoza, Argentina

1995 - 1998          Especialista en Neurología. Pontificia Universidad Católica de Chile

1998                    Visiting fellow. Department of Neurology, Mayo Clinic, EEUU

1999 - 2001          Fellowship en Epilepsia. Klinik für Epileptologie. Bonn, Alemania

2001                    Visiting fellow en Medicina del Sueño. Bielefeld, Alemania

2001 - 2004          Servicio de Neurologia y Psiquiatría. Universität Marburg, Alemania

2004 - 2006          Epilepsiezentrum. Universität Freiburg, Alemania

2007 - 2009          Director del programa de Medicina del Sueño. Hospital Ruber Internacional, Madrid

2011 - 2014          Profesor Asoc. de Neurología. Universitat Autònoma de Barcelona

2014 - actual         Profesor Asoc. de Bioingeniería. Universitat Pompeu Fabra

2009 - actual         Director del Centro de Referencia Europeo en Epilepsia. Hospital del Mar, Barcelona

2017 - actual         Director de la Unidad de Diagnóstico Avanzado en Epilepsia. Hospital Universitario Dexeus, Barcelona


Grados profesionales:

Doctor en Medicina. Rheinische Friedrich-Wilhelms-Universität Bonn

Profesor asociado. Universitat Pompeu Fabra (UPF)

Título médico alemán (Aprobation als Arzt)

Título de Especialista en Neurología alemán (Facharzt für Neurologie)

Especialista en Epilepsia. Sección alemana de la Liga Internacional Contra la Epilepsia (ILAE)

Especialista en Medicina del Sueño. Sociedad Alemana de Medicina del Sueño (DGSM)

German board in EEG. Sociedad Alemana de Neurofisiología Clínica (DGKN)

German board in PSG. Sociedad Alemana de Neurofisiología Clínica (DGKN)

Publicaciones seleccionadas

  1. Vila-Vidal M, Principe A, Ley M, Deco G, Tauste Campo A, Rocamora R. Detection of recurrent activation patterns across focal seizures: Application to seizure onset zone identification. Clin Neurophysiol. 2017 Apr 3;128(6):977-985. [IF: 3.426]
  2. Martin Holtkamp, Ettore Beghi, Felix Benninger, Reetta Kalviainen, Rodrigo Rocamora and Hanne Christensen For the European Stroke Organisation European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. European Stroke Journal 2017, Vol. 2(2) 103–115 [IF 3.754]
  3. B. Kundermann, A. Thum, R. Rocamora, A. Haag, J. C. Krieg, and U. Hemmeter, "Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer's disease and frontotemporal dementia," (in eng), J Psychiatr Res, vol. 45, no. 12, pp. 1585-92, Dec 2011. [IF: 4.664; citations: 12]
  4. M. Ley, A. Principe, J. Jiménez-Conde, and R. Rocamora, "Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests," (in eng), Epilepsy Res, vol. 115, pp. 147-52, Sep 2015. [IF: 4.664; citations: 1]
  5. M. Ley, R. Vivanco, A. Massot, J. Jiménez, J. Roquer, and R. Rocamora, "[Safety study of long-term video-electroencephalogram monitoring]," (in spa), Neurologia, vol. 29, no. 1, pp. 21-6, 2014 Jan-Feb 2014. [IF: 3.957; citations: 1]
  6. Massot, R. Vivanco, A. Principe, J. Roquer, and R. Rocamora, "Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results," (in eng'spa), Neurologia, vol. 29, no. 2, pp. 94-101, Mar 2014. [IF: 1.381; citations: 17]
  7. J. Peltola, M. Holtkamp, R. Rocamora, P. Ryvlin, K. Sieradzan, and V. Villanueva, "Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion," (in eng), Epilepsy Behav, vol. 50, pp. 46-9, Sep 2015. [IF: 2.257; citations: 3]
  8. R. Rocamora, "A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures," (in eng), Ther Adv Neurol Disord, vol. 8, no. 4, pp. 178-86, Jul 2015. [IF: 4; citations: 3]
  9. R. Rocamora, R. G. Andrzejak, J. Jiménez-Conde, and C. E. Elger, "Sleep modulation of epileptic activity in mesial and neocortical temporal lobe epilepsy: a study with depth and subdural electrodes," (in eng), Epilepsy Behav, vol. 28, no. 2, pp. 185-90, Aug 2013. [IF: 2.061; citations: 3]
  10. R. Rocamora et al., "Pilomotor seizures: an autonomic semiology of limbic encephalitis?," (in eng), Seizure, vol. 23, no. 8, pp. 670-3, Sep 2014. [IF: 1.822; citations: 15]
  11. R. Rocamora, A. Gil-Nagel, O. Franch, and A. Vela-Bueno, "Familial recurrent hypersomnia: two siblings with Kleine-Levin syndrome and menstrual-related hypersomnia," (in eng), J Child Neurol, vol. 25, no. 11, pp. 1408-10, Nov 2010. [IF: 1.668; citations: 5]
  12. R. Rocamora, M. Kurthen, L. Lickfett, J. Von Oertzen, and C. E. Elger, "Cardiac asystole in epilepsy: clinical and neurophysiologic features," (in eng), Epilepsia, vol. 44, no. 2, pp. 179-85, Feb 2003. [IF: 4.571; citations: 121]
  13. R. Rocamora, I. Mader, J. Zentner, and A. Schulze-Bonhage, "Epilepsy surgery in patients with multiple cerebral cavernous malformations," (in eng), Seizure, vol. 18, no. 4, pp. 241-5, May 2009. [IF: 2.233; citations: 20]
  14. R. Rocamora, P. Mendivil, and A. Schulze-Bonhage, "[Multiple supratentorial cavernomas and epilepsy surgery: case report]," (in spa), Neurocirugia (Astur), vol. 19, no. 3, pp. 257-63; discussion 263-6, Jun 2008. [IF: 0.277; citations: 2]
  15. R. Rocamora, J. C. Sánchez-Alvarez, and J. Salas-Puig, "The relationship between sleep and epilepsy," (in eng), Neurologist, vol. 14, no. 6 Suppl 1, pp. S35-43, Nov 2008. [IF: 2.083; citations: 4]
  16. R. Rocamora, K. Wagner, and A. Schulze-Bonhage, "Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy," (in eng), Seizure, vol. 15, no. 6, pp. 428-33, Sep 2006. [IF: 2.179; citations: 21]
  17. P. J. Serrano-Castro, J. A. Mauri-Llerda, A. Garcia, R. Rocamora, A. Pardo-Merino, and P. Garcia-Garcia, "[Treatment adherence with levetiracetam: a non-interventionist retrospective observation-based study]," (in spa), Rev Neurol, vol. 62, no. 11, pp. 481-6, Jun 2016. [IF: 0.830; citations: -]
  18. M. Suárez-Piñera et al., "Perfusion SPECT, SISCOM and PET (18)F-FDG in the assessment of drug- refractory epilepsy patients candidates for epilepsy surgery," (in eng'spa), Rev Esp Med Nucl Imagen Mol, vol. 34, no. 6, pp. 350-7, 2015 Nov-Dec 2015. [IF: 0,983; citations: 1]
  19. V. Villanueva et al., "EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy," Neurologia, Jun 2016. [IF: 1.381; citations: 1]
Versión para imprimir Versión para imprimir | Mapa del sitio
© Epilepsia Barcelona - Dr. Rodrigo Rocamora